EIKN position history
The shares of Eikon Therapeutics (EIKN) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 35,742 shares, $466K, <0.01% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|